These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 18809609

  • 1. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
    Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY.
    J Clin Oncol; 2008 Nov 10; 26(32):5269-74. PubMed ID: 18809609
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V, Ferraro G, Pergolizzi S, Sergi C, Laudani A, Settineri N, Alafaci E, Scimone A, Spano F, Spitaleri G.
    Oral Oncol; 2004 May 10; 40(5):525-31. PubMed ID: 15006626
    [Abstract] [Full Text] [Related]

  • 4. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Loibl S, Murmann C, Schwedler K, Warm M, Müller L, Heinrich G, Nekljudova V, von Minckwitz G.
    Cancer Chemother Pharmacol; 2009 Apr 10; 63(5):953-8. PubMed ID: 18716777
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
    Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PC, Marreaud S, Van Glabbeke M, Blay JY.
    Eur J Cancer; 2008 Nov 10; 44(16):2433-6. PubMed ID: 18771914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J, Rai Y, Tamura K, Taki T, Hisamatsu K, Ito Y, Seriu T, Tajima T.
    Anticancer Res; 2009 Feb 10; 29(2):625-30. PubMed ID: 19331212
    [Abstract] [Full Text] [Related]

  • 8. A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
    Lin CC, Cheng AL, Hsu CH, Lu YS, Hsu C, Yeh KH, Wu CY, Huang CS, Yang CH.
    Anticancer Res; 2007 Feb 10; 27(1B):641-5. PubMed ID: 17348454
    [Abstract] [Full Text] [Related]

  • 9. Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.
    Nisticò C, Bria E, Cuppone F, Fornier M, Sperduti I, Carpino A, Pace A, Cognetti F, Terzoli E.
    Anticancer Drugs; 2007 Jul 10; 18(6):687-92. PubMed ID: 17762397
    [Abstract] [Full Text] [Related]

  • 10. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W, Akiya T, Sato A, Yamaguchi K, Sakuyama T, Nakayama N, Tanabe S, Higuchi K, Sasaki T, Sekikawa T, Tokyo Cooperative Oncology Group (TCOG GI Group).
    Jpn J Clin Oncol; 2009 Nov 10; 39(11):713-9. PubMed ID: 19812061
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer.
    Tahara M, Minami H, Hasegawa Y, Tomita K, Watanabe A, Nibu K, Fujii M, Onozawa Y, Kurono Y, Sagae D, Seriu T, Tsukuda M.
    Cancer Chemother Pharmacol; 2011 Sep 10; 68(3):769-76. PubMed ID: 21181475
    [Abstract] [Full Text] [Related]

  • 13. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial.
    Markman M, Liu PY, Wilczynski S, Monk B, Copeland LJ, Alvarez RD, Jiang C, Alberts D, Southwest Oncology Group, Gynecologic Oncology Group.
    J Clin Oncol; 2003 Jul 01; 21(13):2460-5. PubMed ID: 12829663
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
    Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES.
    Cancer; 1999 Nov 15; 86(10):2034-7. PubMed ID: 10570428
    [Abstract] [Full Text] [Related]

  • 15. Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer.
    Saif MW, Podoltsev NA, Rubin MS, Figueroa JA, Lee MY, Kwon J, Rowen E, Yu J, Kerr RO.
    Cancer Invest; 2010 Feb 15; 28(2):186-94. PubMed ID: 19968498
    [Abstract] [Full Text] [Related]

  • 16. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R, Osaki A, Toge T.
    Oncol Rep; 2003 Feb 15; 10(1):145-50. PubMed ID: 12469161
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.
    Chugh R, Dunn R, Zalupski MM, Biermann JS, Sondak VK, Mace JR, Leu KM, Chandler WF, Baker LH.
    J Clin Oncol; 2005 May 20; 23(15):3597-604. PubMed ID: 15908670
    [Abstract] [Full Text] [Related]

  • 18. Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.
    Gennari A, Amadori D, De Lena M, Nanni O, Bruzzi P, Lorusso V, Manzione L, Conte PF.
    J Clin Oncol; 2006 Aug 20; 24(24):3912-8. PubMed ID: 16921042
    [Abstract] [Full Text] [Related]

  • 19. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y, Shu Y, Xu Q.
    Biomed Pharmacother; 2009 May 20; 63(4):293-6. PubMed ID: 18848761
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S, Breda E, Scambia G, Pisano C, Zagonel V, Lorusso D, Greggi S, De Vivo R, Ferrandina G, Gallo C, Perrone F.
    Crit Rev Oncol Hematol; 2008 Jun 20; 66(3):229-36. PubMed ID: 18243011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.